Individual determinants of COVID-19 vaccine hesitancy.
<h4>Background</h4>Novel coronavirus disease 2019 (COVID-19) vaccine hesitancy is a barrier to achieving herd immunity, and thus, a prominent public health concern. This study aimed to identify the determinants of COVID-19 vaccine hesitancy based on the World Health Organization's &...
Guardado en:
Autores principales: | , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/89e2080bd85d4353bd7a9e1501c3a659 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:89e2080bd85d4353bd7a9e1501c3a659 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:89e2080bd85d4353bd7a9e1501c3a6592021-12-02T20:16:20ZIndividual determinants of COVID-19 vaccine hesitancy.1932-620310.1371/journal.pone.0258462https://doaj.org/article/89e2080bd85d4353bd7a9e1501c3a6592021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0258462https://doaj.org/toc/1932-6203<h4>Background</h4>Novel coronavirus disease 2019 (COVID-19) vaccine hesitancy is a barrier to achieving herd immunity, and thus, a prominent public health concern. This study aimed to identify the determinants of COVID-19 vaccine hesitancy based on the World Health Organization's '3Cs' model (i.e., confidence, complacency, and convenience) in the United States (U.S.) and Canada.<h4>Methods</h4>Data from 7678 adults ages 18 or older were collected from the four most populous U.S. States, specifically New York, California, Florida, and Texas, and from English-speaking Canada at three timepoints, in May and July 2020, and March 2021 using a web-based survey (www.covid19-database.com). Sociodemographic information was collected, and comprehensive psychological assessments were administered. Univariate analyses were performed to identify the individual determinants of vaccine hesitancy, which were categorized as: 1) vaccine confidence, 2) vaccine complacency, 3) sociodemographic, and 4) other psychological factors. A series of models were computed using these categorizations.<h4>Results</h4>Mistrust of vaccine benefit (β(SE) = 0.67(0.01), p<0.001, partial η2 = 0.26) and lower perceived seriousness of COVID-19 (β(SE) = 0.68(0.02), p<0.001, partial η2 = 0.12) were the principal determinants of vaccine hesitancy. Right-wing political affiliation (β(SE) = 0.32(0.02), p<0.001, partial η2 = 0.03), higher risk propensity (β(SE) = 0.24(0.02), p<0.001, partial η2 = 0.03), and less negative mental health effects of the COVID-19 pandemic (β(SE) = 0.20(0.01), p<0.001, partial η2 = 0.03) were the main sociodemographic and psychological determinants. Other sociodemographic determinants included younger age, women, race, and employment status. Lack of vaccine confidence and complacency explained 38% and 21% of the variance in vaccine hesitancy, respectively; whereas, sociodemographic and psychological determinants explained 13% and 11% of the variance in vaccine hesitancy, respectively.<h4>Discussion</h4>Targeted and tailored public health interventions that enhance the public's confidence in vaccines and emphasize the risk and seriousness of COVID-19 may address COVID-19 vaccine hesitancy. Efforts directed toward specific marginalized and underserved groups may be required to promote vaccine confidence.Philip GerretsenJulia KimFernando CaravaggioLena QuiltyMarcos SanchesSamantha WellsEric E BrownBranka AgicBruce G PollockAriel Graff-GuerreroPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 11, p e0258462 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Philip Gerretsen Julia Kim Fernando Caravaggio Lena Quilty Marcos Sanches Samantha Wells Eric E Brown Branka Agic Bruce G Pollock Ariel Graff-Guerrero Individual determinants of COVID-19 vaccine hesitancy. |
description |
<h4>Background</h4>Novel coronavirus disease 2019 (COVID-19) vaccine hesitancy is a barrier to achieving herd immunity, and thus, a prominent public health concern. This study aimed to identify the determinants of COVID-19 vaccine hesitancy based on the World Health Organization's '3Cs' model (i.e., confidence, complacency, and convenience) in the United States (U.S.) and Canada.<h4>Methods</h4>Data from 7678 adults ages 18 or older were collected from the four most populous U.S. States, specifically New York, California, Florida, and Texas, and from English-speaking Canada at three timepoints, in May and July 2020, and March 2021 using a web-based survey (www.covid19-database.com). Sociodemographic information was collected, and comprehensive psychological assessments were administered. Univariate analyses were performed to identify the individual determinants of vaccine hesitancy, which were categorized as: 1) vaccine confidence, 2) vaccine complacency, 3) sociodemographic, and 4) other psychological factors. A series of models were computed using these categorizations.<h4>Results</h4>Mistrust of vaccine benefit (β(SE) = 0.67(0.01), p<0.001, partial η2 = 0.26) and lower perceived seriousness of COVID-19 (β(SE) = 0.68(0.02), p<0.001, partial η2 = 0.12) were the principal determinants of vaccine hesitancy. Right-wing political affiliation (β(SE) = 0.32(0.02), p<0.001, partial η2 = 0.03), higher risk propensity (β(SE) = 0.24(0.02), p<0.001, partial η2 = 0.03), and less negative mental health effects of the COVID-19 pandemic (β(SE) = 0.20(0.01), p<0.001, partial η2 = 0.03) were the main sociodemographic and psychological determinants. Other sociodemographic determinants included younger age, women, race, and employment status. Lack of vaccine confidence and complacency explained 38% and 21% of the variance in vaccine hesitancy, respectively; whereas, sociodemographic and psychological determinants explained 13% and 11% of the variance in vaccine hesitancy, respectively.<h4>Discussion</h4>Targeted and tailored public health interventions that enhance the public's confidence in vaccines and emphasize the risk and seriousness of COVID-19 may address COVID-19 vaccine hesitancy. Efforts directed toward specific marginalized and underserved groups may be required to promote vaccine confidence. |
format |
article |
author |
Philip Gerretsen Julia Kim Fernando Caravaggio Lena Quilty Marcos Sanches Samantha Wells Eric E Brown Branka Agic Bruce G Pollock Ariel Graff-Guerrero |
author_facet |
Philip Gerretsen Julia Kim Fernando Caravaggio Lena Quilty Marcos Sanches Samantha Wells Eric E Brown Branka Agic Bruce G Pollock Ariel Graff-Guerrero |
author_sort |
Philip Gerretsen |
title |
Individual determinants of COVID-19 vaccine hesitancy. |
title_short |
Individual determinants of COVID-19 vaccine hesitancy. |
title_full |
Individual determinants of COVID-19 vaccine hesitancy. |
title_fullStr |
Individual determinants of COVID-19 vaccine hesitancy. |
title_full_unstemmed |
Individual determinants of COVID-19 vaccine hesitancy. |
title_sort |
individual determinants of covid-19 vaccine hesitancy. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2021 |
url |
https://doaj.org/article/89e2080bd85d4353bd7a9e1501c3a659 |
work_keys_str_mv |
AT philipgerretsen individualdeterminantsofcovid19vaccinehesitancy AT juliakim individualdeterminantsofcovid19vaccinehesitancy AT fernandocaravaggio individualdeterminantsofcovid19vaccinehesitancy AT lenaquilty individualdeterminantsofcovid19vaccinehesitancy AT marcossanches individualdeterminantsofcovid19vaccinehesitancy AT samanthawells individualdeterminantsofcovid19vaccinehesitancy AT ericebrown individualdeterminantsofcovid19vaccinehesitancy AT brankaagic individualdeterminantsofcovid19vaccinehesitancy AT brucegpollock individualdeterminantsofcovid19vaccinehesitancy AT arielgraffguerrero individualdeterminantsofcovid19vaccinehesitancy |
_version_ |
1718374479192653824 |